Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar 27:2018:bcr2017223209.
doi: 10.1136/bcr-2017-223209.

When a transfusion in an emergency service is not really urgent: hyperhaemolysis syndrome in a child with sickle cell disease

Affiliations
Case Reports

When a transfusion in an emergency service is not really urgent: hyperhaemolysis syndrome in a child with sickle cell disease

Sara Chinchilla Langeber et al. BMJ Case Rep. .

Abstract

A 13-month-old boy with sickle cell disease (SCD) from Equatorial Guinea, who had recently arrived in Spain, presented with fever. He had suffered from malaria and had received a blood transfusion. Following physical examination and complementary tests, intravenous antibiotics and a red blood cell (RBC) transfusion were administered. Soon after a second transfusion 5 days later, the haemoglobin level fell below pretransfusion levels, together with reticulocytopenia, and haematuria-the so-called hyperhaemolysis syndrome-requiring intensive care and treatment with intravenous immunoglobulins and corticosteroids, with resolution of the complication. We want to emphasise the importance of suspecting this rare, though severe complication that can appear after any RBC transfusion especially in patients with SCD, as the clinical syndrome can simulate other more common complications of these patients and a further transfusion is contraindicated. There is no standardised treatment, but intravenous immunoglobulin and corticosteroids are usually effective.

Keywords: haematology (drugs and medicines); haematology (incl blood transfusion); paediatrics (drugs and medicines).

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Progress during admission. Hb, haemoglobin; IVIG, intravenous immunoglobulin; MP, methylprednisolone; Retics, reticulocytes; Bt, blood transfusion.

References

    1. Danaee A, Inusa B, Howard J, et al. . Hyperhemolysis in patients with hemoglobinopathies: a single-center experience and review of the literature. Transfus Med Rev 2015;29:220–30. 10.1016/j.tmrv.2015.06.001 - DOI - PubMed
    1. Aragona E, Kelly MJ. Hyperhemolysis in sickle cell disease. J Pediatr Hematol Oncol 2014;36:e54–e56. 10.1097/MPH.0b013e31828e529f - DOI - PubMed
    1. Eberly LA, Osman D, Collins NP. Hyperhemolysis syndrome without underlying hematologic disease. Case Rep Hematol 2015;2015:1–3. 10.1155/2015/180526 - DOI - PMC - PubMed
    1. Cervera A, Rueda F, Benedit M, et al. . Drepanocitosis y paludismo: agravación de la enfermedad de base. An Esp Pediatr 1997;47:191–4. - PubMed
    1. Mongella S, Enweji N, Mnong’one N, et al. . High prevalence of Plasmodium falciparum pfcrt K76T mutation in children with sickle cell disease at a tertiary hospital in north-western Tanzania. Tanzan J Health Res 2014;16:256–60. 10.4314/thrb.v16i4.1 - DOI - PubMed

Publication types

Substances

LinkOut - more resources